Position in PMVP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$124,682
-$18,441 QoQ
Shares Held
93,047
-19.4% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 64 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. PMVP ranks #347 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in PMVP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,682 | 93,047 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $143,123 | 115,422 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $477,609 | 382,088 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $533,137 | 380,813 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $122,596 | 115,657 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $117,007 | 107,346 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $162,083 | 107,340 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $129,853 | 87,150 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $524,409 | 323,710 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $574,826 | 338,134 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,014,393 | 327,224 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,085,935 | 339,729 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,008,194 | 320,798 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,471,573 | 308,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,790,376 | 320,733 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,766,563 | 316,518 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,462,201 | 313,137 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,116,680 | 245,758 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,758,667 | 249,293 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $7,541,664 | 253,076 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,865,031 | 259,515 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,322,488 | 161,827 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $9,612,659 | 156,278 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $567,219 | 15,978 | Shares | Other | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||